Alicia M Fry Selected Research

Alicia M Fry Research Topics

Disease

123	Human Influenza (Influenza) 03/2022 - 12/2006
40	Infections 03/2022 - 03/2009
12	COVID-19 11/2021 - 01/2020
11	Pneumonia (Pneumonitis) 07/2020 - 12/2002
6	Virus Diseases (Viral Diseases) 05/2016 - 01/2011
5	Fever (Fevers) 10/2021 - 04/2011
4	Respiratory Tract Infections (Respiratory Tract Infection) 10/2021 - 01/2018
4	Communicable Diseases (Infectious Diseases) 01/2019 - 11/2004
2	Egg Hypersensitivity (Egg Allergy) 01/2020 - 01/2018
2	Pharyngitis (Sore Throat) 01/2019 - 01/2018
2	Asthma (Bronchial Asthma) 01/2017 - 01/2013
2	Herpesviridae Infections (Herpesvirus Infection) 02/2014 - 03/2013
2	Trachoma 11/2004 - 02/2003
1	Anaphylaxis (Anaphylactic Shock) 01/2021
1	Hypersensitivity (Allergy) 01/2021
1	Breakthrough Infections 01/2021
1	Drug-Related Side Effects and Adverse Reactions 12/2020
1	Lung Diseases (Lung Disease) 07/2020
1	Frailty 01/2019
1	Rhinorrhea 01/2019
1	Bronchitis 01/2018
1	Sinusitis 01/2018
1	Poliomyelitis (Polio) 12/2017
1	Influenza in Birds (Avian Flu) 09/2017
1	Cough 05/2016
1	Body Weight (Weight, Body) 05/2015
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2013
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2013
1	Respiratory Insufficiency (Respiratory Failure) 04/2011
1	Vomiting 04/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2005
1	Pneumococcal Infections 12/2002

Drug/Important Bio-Agent (IBA)

57	VaccinesIBA 03/2022 - 12/2002
53	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2022 - 03/2010
44	Antiviral Agents (Antivirals)IBA 03/2022 - 12/2009
26	Oseltamivir (Tamiflu)FDA Link 10/2021 - 03/2009
12	Neuraminidase (Sialidase)IBA 05/2016 - 03/2011
6	Pharmaceutical PreparationsIBA 05/2015 - 11/2004
5	COVID-19 VaccinesIBA 11/2021 - 12/2020
5	Hemagglutinins (Hemagglutinin)IBA 01/2021 - 12/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2020 - 02/2003
5	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2020 - 11/2009
4	Messenger RNA (mRNA)IBA 11/2021 - 01/2021
4	mRNA VaccinesIBA 11/2021 - 01/2021
4	AntibodiesIBA 10/2021 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2016
2	2019-nCoV Vaccine mRNA-1273IBA 04/2021 - 01/2021
2	BNT162 VaccineIBA 04/2021 - 01/2021
2	Inactivated VaccinesIBA 01/2021 - 12/2018
2	Attenuated VaccinesIBA 01/2021 - 10/2017
2	FluMistIBA 06/2018 - 01/2017
2	AntigensIBA 10/2017 - 12/2002
2	Particulate MatterIBA 08/2017 - 05/2014
2	insulin receptor-related receptor (IRR)IBA 01/2017 - 12/2006
2	Dihydrotachysterol (AT 10)IBA 12/2013 - 12/2010
2	AdamantaneIBA 01/2011 - 11/2010
1	Complement System Proteins (Complement)IBA 11/2021
1	N 30IBA 10/2021
1	Viral RNAIBA 01/2021
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2021
1	Combined VaccinesIBA 01/2021
1	EndonucleasesIBA 01/2019
1	baloxavirIBA 01/2019
1	CI 22IBA 01/2019
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019
1	FluLavalIBA 01/2017
1	AfluriaIBA 01/2017
1	FluBlokIBA 01/2017
1	NucleoproteinsIBA 05/2016
1	Zanamivir (Relenza)FDA Link 10/2015
1	Soaps (Soap)IBA 06/2015
1	oplunofuspIBA 08/2014
1	TinIBA 05/2014
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2013
1	RNA (Ribonucleic Acid)IBA 04/2012
1	EnzymesIBA 04/2011
1	peramivirIBA 03/2011
1	MacrolidesIBA 02/2003
1	Azithromycin (Zithromax)FDA LinkGeneric 02/2003
1	Polysaccharides (Glycans)IBA 12/2002
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 12/2002

Therapy/Procedure

7	Contraindications 01/2021 - 01/2017
6	Therapeutics 10/2021 - 01/2012
5	Artificial Respiration (Mechanical Ventilation) 01/2021 - 03/2005
4	Ambulatory Care (Outpatient Care) 12/2020 - 09/2014
4	Chemoprevention 01/2019 - 01/2012
3	Length of Stay 10/2021 - 12/2005
2	Personal Protective Equipment 12/2020 - 01/2019
1	Hand Hygiene 12/2020
1	Activities of Daily Living (ADL) 07/2020
1	Long-Term Care 12/2009
1	Tracheostomy 03/2005